TCT-224 A Study On The Impact Of CYP2C19 Genotype And Platelet Reactivity Assay On Patients Undergoing PCI

TCT-224 A Study On The Impact Of CYP2C19 Genotype And Platelet Reactivity Assay On Patients Undergoing PCI

Methods Between August 2013 and August 2014, 200 patients with coronary artery disease undergoing percutaneous coronary intervention (PCI) were prescribed any one of the antiplateletmedications such as clopidogrel, prasugrel or ticagrelor and offered testing to detect CYP2C19 gene mutations along wi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2015-10, Vol.66 (15), p.B87-B87
Hauptverfasser: Sundar Chidambaram, Rath, Prathap C, Byomakesh Dixit, Rath, Pallavi
Format: Artikel
Sprache:eng
Schlagworte:
Blood platelets
Cardiology
Cardiovascular
Cardiovascular disease
Genotype & phenotype
Internal Medicine
Metabolism
Patients
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Methods Between August 2013 and August 2014, 200 patients with coronary artery disease undergoing percutaneous coronary intervention (PCI) were prescribed any one of the antiplateletmedications such as clopidogrel, prasugrel or ticagrelor and offered testing to detect CYP2C19 gene mutations along with a platelet reactivity assay (PRA).
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2015.08.239